39
Views
19
CrossRef citations to date
0
Altmetric
Research Article

Postoperative Radiotherapy after Prostatectomy A Review

, , , &
Pages 10-15 | Published online: 09 Jul 2009

  • Paulson DF. Robertsoti CN. Positive margins: is adjunctive radiation therapy indicated. Acta Oncol 1991: 30:263-5.
  • Hisbruch A. Peretz. CA. Roessler EH. Lockett MA. Adjuvant irradiation after prostatectomy for carcinoma of the prostate with positive sursical maruins. Cancer 1994: 73: 384-7.
  • Schild SR. Wong WW. Grado Gl et al. The results of radical retropubic prostatectomy and adjuvant therapy for pathologic stage C prostate cancer. Int J Radial Oncol Biol Phys 1996: 34: 535 41.
  • Zietman Al. Coen JJ. Shipley WU. Althausen AF. Adjuvant irradiation after radical prostatectomy for adenocarcinoma of the prostate: analysis of freedom from PSA failure. Urology 1993: 42: 292-9.
  • Link P. Freiha HS. Stamey TA. Adjuvant radiation therapy in patients with detectable prostate specific antigen following radical prostatectomy. J Urol 1991; 145: 532-4.
  • Conolly JA. Presti JC- Jr, Cher ML. Chew K. Shiohara K, Carrol 1 PR. Accelerated tumor proliferation rates in locally recurrent prostate cancer after radical prostatectomy. J Uron 1997; 158:515-8.
  • George FW. Carlton CE. Dykhuizen RF. Dillon JR. Cobalt-60 telecurietherapy in the definitive treatment of carcinomas of the prostate: a preliminary report. J Urol 1965:93: 102.
  • Ray GR. Cassady JR. Bagshaw MA. External-beam magavoltage radiation treatment of post-radical prostatectomy residual or recurrent tumor: Preliminary results. J Urol 1975: 114: 98-101.
  • Ray GR. Bagshaw MA. Freiha FS. External beam irradiation salvage for residual or recurrent local tumor following radical prostatectomy. J Urol 1984, 132: 926-30.
  • Forman JD. Meetze K. Pontes E. Wood DP. Shamsa F. Rana T. et al. Therapeutic irradiation for patients with an elevated post-prostatectomy prostate specific antigen level. J Urol 1997: 158: 1436-40.
  • Schild ES. Radiation therapy after prostatectomy: Now or later. Sem Radiat Oncol 1998: 8: 132-9.
  • Ansehcr MS, Robertson CN. Prosnitz. R. Adjuvant radiotherapy for pathologic stage PT3/4 adenocareinoma of the prostate: ten-year update, lnt J Radial Oncol Biol Phys 1995:33: 37-43.
  • Morgan WR. Zinke H, Rainwater LM. Mayers RP Klee GG. Prostate specitic antigen values after radical retropubic prostatectomy foradenocareinoma of the prostate: impact of adjuvant treatment (hormonal and radiation). J Urol 1991; 145: 319-23.
  • Morris MM, Dallow KC. Zietman Al. et al. Adjuvant and salvage irradiation following radical prostatectomy for prostate cancer. Int J Radiat Oncol Biol Phys 1997; 38: 731-36.
  • Petrovich Z. Lieskovsky O. Langholz B. Formenti S, Baert L, Streeter O. et al. Radical prostatectomy and postoperative irradiation in patients with pathological stage C (PT3) carcinoma of the prostate. lnt J Radial Oncol Biol Phys 1998: 40: 139-47.
  • Perez CA. Prostate. In Principles and practice of radiation oncology. Perez. CA. Brady LW (Eds). JB Lippincott Company, Philadelphia 1992. pp. 1067-1116.
  • Cheng WS. Fryndenberg M. Bergstrahl EJ. Larsson Keller JJ. Zincke H. Radical prostatectomy for pathologic stage C prostate cancer: influence of pathologic variables and adjuvant treatment on disease outcome. Urology 1993:42: 283-91.
  • Meier R. Mark R. St Royal L. Tran L. Colburn G. Parker R. Postoperative radiation therapy after radical prostatectomy for prostate carcinoma. Cancer 1992: 70: 1960-66.
  • Gibbons RP. Cole BS. Richardson RG, et al. Adjuvant radiotherapy following radical prostatectomy: results and complications. J Uron 1986: 135: 65-8.
  • Paulson DF, Moul JW, Robertson JE. Walther PJ. Postoperative radiotherapy of the prostate for patients undergoing radical prostatectomy with positive margins, seminal vesicle involvement and/or penetralion through the capsule. J Urol 1990; 143: 1178-83.
  • Mukarnel E. deKernion JB. Hannah J, Smith RB. Skinner DG. Goodwill WE. The incidence and significance of seminal vesicle invasion in patients with adenocareinoma of the prostate. Cancer 1987; 59: 1535-8.
  • Jhaveri FM. Zippe CD. Klein KA. Kupelian PA. Biochemical failure does not predict overall survival after radical prostatectomy for localized prostate cancer: 10 year results. Urology 1999: 54: 884-90.
  • Roach M III. The role of PSA in radiotherapy of prostatic cancer. Oncology Huntingt 1996:10:1143-61.
  • Hanks GE. Martz. KL. Diamond JJ. The effect of dose on local control of prostatic cancer, lnt J Radiat Oncon Biol Phys 1988: 15: 1299-305.
  • Nudell DM. Grossfeld GD. Weinberg VK. Roach M III. Carroll PR. Radiotherapy after radical prostatectomy: treatments outcomes and failure patterns. Urology 1999: 54:1049-57.
  • D'Amigo AV. Whitiington R. Malkowies SB. Schultz D. Tomaszewski JE. Wein A. Prostate-specific antigen failure despite pathologically organ-defined and margin-negative prostate cancer: the basis for an adjuvant therapy trial. J Clin Oncol 1997; 15: 465-9.
  • McCarthy JF. Catalona WJ. Hudson MA. Effect of radiation therapy on delectable serum prostate specific antigen levels following radical prostatectomy: early versus delayed treatment. J Uron 1994: 151: 1575-78.
  • Grossfeld GD. Tigrani VS. Nudell D. Roach M III. Weinberg VK. Presti JC Jr. Small EJ. Management of a positive surgical margin after radical prostatectomy: decision analysis. J Urol 2000; 164: 93-9.
  • Schild SE. Radiation therapy after prostatectomy: the case for salvage therapy as opposed to adjuvant therapy, lnt J Cancer 2001:96: 94-8.
  • Anscher MS. Adjuvant radiotherapy following radical prostatectomy is more effective and less toxic then salvage radiotherapy for a rising prostate specific antigen, lnt J Cancer 2001; 96: 91-3.
  • Van Poppel H. Vanuytsel L. Petrovich Z. et al. Current controversis in cancer. Is postoperative irradiation after radical prostatectomy necessary. Eur J Cancer 1999: 35: 1763-70.
  • Petrovich Z., Lieskovsky G. Langholz B. Luxton G. Jozef G. Skinner DG. Radiotherapy following radical prostatectomy in patients with adenocarcinoma of the prostate, lnt J Radiat Oncol Biol Phys 1991: 21: 949 54.
  • Gervasi LA. Mata J. Easley JD. Wilbanks JH. SealeHawkins C. Carlton CE. et al. Prognostic significance of lymph nodal metastases in prostate cancer. J Uron 1989: 142: 332-6.
  • Bagshaw MA. Radiotherapeutic treatment of prostalic carcinoma with pelvic node involvement. Urol Clin N Am 1984: 11: 297-303.
  • Valecenti RK. Gomella LG, Ismail M. Mulhotland SG. Petersen RO. Corn BW. Effect of higher radiation dose on biochemical control after radical prostatectomy for PT3NO prostate cancer, lnt J Radiat Oncol Biol Phys 1998:42:501-6
  • Forman JD. Wharam MD. Lee DJ. Zinreich ES. Order SE. Definitive radiotherapy following prosiatectomy: Results and complications. lnt J Radiat Oncol Biol Phys 1986: 12: 185-9.
  • Lange PH. Moon TD. Narayan P, Medini E. Radiation therapy as adjuvant treatment after radical prostatectomy: patient tolerance and preliminary results. J Urol 1986: 136:45-9.
  • Lange PH. Ercole CJ. Lightner DJ. Fraley EK. Vessella R. The value of serum prostate specific antigen determinations before and after radical prostatectomy. J Urol 1989; 141: 873-9.
  • Lange PH, Lightner DJ. Medici E. Reddy PK. Vesella RL. The effect of radiation therapy after radical prostatectomy in patients with elevated prostate specific antigen levels. J Urol 1990: 144: 927-33.
  • Piepich MV. Walz. BJ. Baglan RJ. Postoperative irradiation in carcinoma of the prostate, lnt J Radiat Oncol Biol Phys 1984; 10: 1869-73.
  • Wiegel T. Bressel M. Arps H. Hubener KH. Radiotherapy of local recurrence following radical prostatec tomy. Strahlenther Oncol 1992; 168: 333-6.
  • Catton C. Gospodarowics M. Warde P. Panzarella T, Cation P. McLean M. et al. Adjuvant and salvage radiation therapy after radical prostataectomy for adenocarcinoma of the prostate. Rad Oncol 2001: 59: 51-60.
  • Edgren M, Lennernas B. Haggman M. Norlen BJ. Nilsson S. Postoperative radiotherapy after prostatectomy can be associated with severe side effects. Anticancer Res 2001: 21(3C): 2231-5.
  • Lennernäs B. Letocha H. Rikner G. Magnusson A. Nilsson S. Field displacement during external radiotherapy in prostatic adenocarcinoma treated with radioactive 198-Au implants and external irradiation. Acta Oncol 1995; 34: 959-64.
  • Omstein DK, Colberg JW. Virgo KS. Chan D, Johnson ET. Oh J. et al. Evaluation and management of men whose radical prostatectomies failed: Results of an international survey. Urology 1998; 52: 1047-54.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.